Back to search results

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

Abroad (travel likely)RecruitingPHASE2

Conditions

Hypophosphatemia · Kidney Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Stanford University, Stanford, California, United States

    Contact: Study coordinator (Pari Waghela, MS) · pariw@stanford.edu · 650-724-8441
    Contact: Principal Investigator (Stephan Busque, MD)
Study leads

  • Stephan Busque, MD

    Principal Investigator

    Stanford University

View source on ClinicalTrials.gov(opens in a new tab)